Literature DB >> 11040048

Overexpression of type 7 adenylyl cyclase in the mouse brain enhances acute and chronic actions of morphine.

M Yoshimura1, P H Wu, P L Hoffman, B Tabakoff.   

Abstract

The mechanisms by which morphine-induced analgesia and tolerance and physical dependence on morphine arise have been the subject of intense study, and much work has pointed to the involvement of cAMP-mediated events in the neuroadaptive phenomena leading to morphine tolerance and/or dependence. We overexpressed an opioid receptor-stimulatable form of adenylyl cyclase (type 7) in the central nervous system of mice and demonstrated significant effects of this manipulation on the animals' acute response to morphine, the development of morphine tolerance, and development of sensitization to morphine. Measurements of the acute analgesic response to morphine demonstrated that the ED(50) values for the transgenic mice were significantly lower than the ED(50) values determined for the "wild-type" animals. During chronic treatment with morphine, the transgenic mice developed tolerance more rapidly than the wild-type mice, and transgenic animals of the C57BL/6xSJL background showed a larger sensitization to morphine's effects on locomotor activity than did wild-type mice of the same background. These results indicated that cAMP-generating systems may simultaneously modulate the development of tolerance and sensitization. Interestingly, the signs of physical dependence on morphine in the transgenic mice did not differ from those in their wild-type litter mates, indicating that separate mechanisms may modulate opiate tolerance and opiate dependence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040048     DOI: 10.1124/mol.58.5.1011

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Type 7 adenylyl cyclase-mediated hypothalamic-pituitary-adrenal axis responsiveness: influence of ethanol and sex.

Authors:  Sergey P Pronko; Laura M Saba; Paula L Hoffman; Boris Tabakoff
Journal:  J Pharmacol Exp Ther       Date:  2010-04-02       Impact factor: 4.030

Review 2.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 3.  Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies.

Authors:  Rachna Sadana; Carmen W Dessauer
Journal:  Neurosignals       Date:  2008-10-24

4.  Pharmacological profiles of opioid ligands at kappa opioid receptors.

Authors:  Parham Gharagozlou; Ezzat Hashemi; Timothy M DeLorey; J David Clark; Jelveh Lameh
Journal:  BMC Pharmacol       Date:  2006-01-25

5.  Acute morphine alters GABAergic transmission in the central amygdala during naloxone-precipitated morphine withdrawal: role of cyclic AMP.

Authors:  Michal Bajo; Samuel G Madamba; Marisa Roberto; George R Siggins
Journal:  Front Integr Neurosci       Date:  2014-06-04

6.  Activity of opioid ligands in cells expressing cloned mu opioid receptors.

Authors:  Parham Gharagozlou; Hasan Demirci; J David Clark; Jelveh Lameh
Journal:  BMC Pharmacol       Date:  2003-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.